HomeCompareDSRLF vs RYLD

DSRLF vs RYLD: Dividend Comparison 2026

DSRLF yields 2.24% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYLD wins by $9.0K in total portfolio value
10 years
DSRLF
DSRLF
● Live price
2.24%
Share price
$67.00
Annual div
$1.50
5Y div CAGR
26%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.5K
Annual income
$3,658.42
Full DSRLF calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — DSRLF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDSRLFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DSRLF + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DSRLF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DSRLF
Annual income on $10K today (after 15% tax)
$190.30/yr
After 10yr DRIP, annual income (after tax)
$3,109.66/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, DSRLF beats the other by $910.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DSRLF + RYLD for your $10,000?

DSRLF: 50%RYLD: 50%
100% RYLD50/50100% DSRLF
Portfolio after 10yr
$40.0K
Annual income
$3,122.88/yr
Blended yield
7.80%
📊

Analyst Conviction Gap

Where Wall Street is split right now

DSRLF
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Altman Z
2.3
Piotroski
5/9
RYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DSRLF buys
0
RYLD buys
0
No recent congressional trades found for DSRLF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDSRLFRYLD
Forward yield2.24%12.14%
Annual dividend / share$1.50$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR26%0%
Portfolio after 10y$35.5K$44.5K
Annual income after 10y$3,658.42$2,587.35
Total dividends collected$13.3K$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: DSRLF vs RYLD ($10,000, DRIP)

YearDSRLF PortfolioDSRLF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$10,982$282.09$11,914$1,213.65$932.00RYLD
2$12,116$364.80$14,099$1,351.30$2.0KRYLD
3$13,438$473.92$16,580$1,494.55$3.1KRYLD
4$14,997$618.97$19,384$1,642.61$4.4KRYLD
5$16,861$813.48$22,535$1,794.70$5.7KRYLD
6$19,118$1,076.94$26,063$1,950.00$6.9KRYLD
7$21,894$1,437.95$29,995$2,107.69$8.1KRYLD
8$25,366$1,939.18$34,361$2,266.99$9.0KRYLD
9$29,787$2,645.62$39,194$2,427.12$9.4KRYLD
10$35,530$3,658.42$44,525$2,587.35$9.0KRYLD

DSRLF vs RYLD: Complete Analysis 2026

DSRLFStock

DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Full DSRLF Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this DSRLF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DSRLF vs SCHDDSRLF vs JEPIDSRLF vs ODSRLF vs KODSRLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.